How Much Will That Be? | GenomeWeb

Just more than a quarter of people have heard of the term 'personalized medicine,' according to a recent survey conducted by GfK Bridgehead, a market research firm. Additionally, as Ed Silverman at Pharmalot notes, many people think that such tailored treatments will lead to a rise in healthcare costs.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Related Posts

In PNAS this week: map of UV-induced damage in yeast genome, comparative epigenomics uncovers plant lacking key DNA methyltransferase enzyme, and more.

Researchers kick off their second Queer in STEM survey to examine what can make STEM careers welcoming, Wired reports.

A startup company is offering a test to analyze soil samples from farms for pathogens.

Prosecutors seek to introduce evidence from low-template DNA analysis in a murder case in upstate New York, the New York Times reports.